HAE – haemonetics corporation (US:NYSE)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

HAE

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

12/18

12:58 pm

hae

HAE or SYK: Which Is the Better Value Stock Right Now? [Yahoo! Finance]

Low Report

HAE or SYK: Which Is the Better Value Stock Right Now? [Yahoo! Finance]

Report

12/6

10:57 am

hae

Are Investors Undervaluing Haemonetics (HAE) Right Now? [Yahoo! Finance]

Low Report

Are Investors Undervaluing Haemonetics (HAE) Right Now? [Yahoo! Finance]

Report

12/6

08:06 am

hae

Haemonetics Co. (NYSE: HAE) is now covered by analysts at JPMorgan Chase & Co.. They set an "overweight" rating and a $116.00 price target on the stock.

Low Report

Haemonetics Co. (NYSE: HAE) is now covered by analysts at JPMorgan Chase & Co.. They set an "overweight" rating and a $116.00 price target on the stock.

Report

12/4

11:28 am

hae

Wall Street Analysts See a 27.84% Upside in Haemonetics (HAE): Can the Stock Really Move This High? [Yahoo! Finance]

Low Report

Wall Street Analysts See a 27.84% Upside in Haemonetics (HAE): Can the Stock Really Move This High? [Yahoo! Finance]

Report

12/4

09:43 am

hae

Haemonetics Co. (NYSE: HAE) had its "outperform" rating re-affirmed by analysts at Barrington Research. They now have a $108.00 price target on the stock.

Low Report

Haemonetics Co. (NYSE: HAE) had its "outperform" rating re-affirmed by analysts at Barrington Research. They now have a $108.00 price target on the stock.

Report

12/3

12:52 pm

hae

Haemonetics Co. (NYSE: HAE) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $112.00 price target on the stock.

Low Report

Haemonetics Co. (NYSE: HAE) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $112.00 price target on the stock.

Report

12/3

01:21 am

hae

Haemonetics Announces Sale of Whole Blood Assets to GVS, S.p.A [Yahoo! Finance]

Low Report

Haemonetics Announces Sale of Whole Blood Assets to GVS, S.p.A [Yahoo! Finance]

Report

12/3

01:16 am

hae

Haemonetics Announces Sale of Whole Blood Assets to GVS, S.p.A

Low Report

Haemonetics Announces Sale of Whole Blood Assets to GVS, S.p.A

Report

11/21

01:34 am

hae

[Latest] Global Apheresis Equipment Market Size/Share Worth USD 13,169.1 Million by 2033 at a 12.2% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value) [Yahoo! Finance]

Low Report

Report

11/15

03:26 pm

hae

Haemonetics Co. (NYSE: HAE) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $112.00 price target on the stock.

Low Report

Haemonetics Co. (NYSE: HAE) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $112.00 price target on the stock.

Report

11/11

09:37 am

hae

Haemonetics' Q2 Earnings and Revenues Top, Stock Up, Margins Expand [Yahoo! Finance]

Medium Report

Haemonetics' Q2 Earnings and Revenues Top, Stock Up, Margins Expand [Yahoo! Finance]

Report

11/8

04:24 pm

hae

Haemonetics Co. (NYSE: HAE) had its "outperform" rating re-affirmed by analysts at Barrington Research. They now have a $108.00 price target on the stock.

Medium Report

Haemonetics Co. (NYSE: HAE) had its "outperform" rating re-affirmed by analysts at Barrington Research. They now have a $108.00 price target on the stock.

Report

11/7

11:31 am

hae

Compared to Estimates, Haemonetics (HAE) Q2 Earnings: A Look at Key Metrics [Yahoo! Finance]

Low Report

Compared to Estimates, Haemonetics (HAE) Q2 Earnings: A Look at Key Metrics [Yahoo! Finance]

Report

11/7

06:00 am

hae

Haemonetics 2nd Quarter Fiscal Year 2025 Earnings Release Available on Investor Relations Website

Medium Report

Haemonetics 2nd Quarter Fiscal Year 2025 Earnings Release Available on Investor Relations Website

Report

11/6

11:24 am

hae

Haemonetics (HAE) Q2 Earnings on the Horizon: Analysts' Insights on Key Performance Measures [Yahoo! Finance]

Low Report

Haemonetics (HAE) Q2 Earnings on the Horizon: Analysts' Insights on Key Performance Measures [Yahoo! Finance]

Report

10/3

04:05 pm

hae

Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2025 Results: November 7, 2024

Low Report

Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2025 Results: November 7, 2024

Report

9/23

11:08 am

hae

Haemonetics Co. (NYSE: HAE) had its "outperform" rating re-affirmed by analysts at Barrington Research. They now have a $108.00 price target on the stock.

Low Report

Haemonetics Co. (NYSE: HAE) had its "outperform" rating re-affirmed by analysts at Barrington Research. They now have a $108.00 price target on the stock.

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.